Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell linesNarendra Wajapeyee, Michael R. Green|Molecular Cancer Therapeutics|2009Cited by 46
ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical modelsSuresh Bugide, Narendra Wajapeyee|iScience|2024Cited by 2